We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Welcome to Episode #200 of the Zacks Market Edge Podcast.
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.
On this special episode, the 200th of the Market Edge Podcast, Kevin Cook, Zacks Senior Equity Strategist and Editor of the Healthcare Innovator newsletter, joins in the discussion on the investing lessons they have both learned over the last 20 years of investing.
What lessons have they learned that other investors can apply to their own strategies?
Two of Kevin’s Key Lessons
1. Trends: technology and healthcare innovation has stood the test of time over the last few decades. Kevin recommended buying the Technology Select SPDR ETF (XLK - Free Report) and the iShares NASDAQ Biotech ETF (IBB - Free Report) back in March 2009 as stocks were plunging. The XLK is up 392% since the March 2009 lows and the IBB is up 391% versus a 251% return on the S&P 500 over the same period. Also, individual companies such as Square (SQ - Free Report) are leading new industries.
2. ETFs: Use them for niche investing. Zacks ETF Investor bought the iShares Semiconductors ETF (SOXX - Free Report) back in 2016. That bet has paid off on a very narrow category in technology.
Two of Tracey’s Top Lessons
1. Buy the Best: don’t settle for the second-best company in the industry just because it may appear to be cheaper. Buy the industry leaders. In the 1990s, Tracey learned a hard lesson thanks to this.
2. You Don’t Have to Buy IPOs: There’s a lot of publicity surrounding “new” IPOs and many investors think it’s the only way to get a big winning stock. But you can buy an IPO years, or decades, later with much success. For example, Berkshire Hathaway recently bought Amazon (AMZN - Free Report) and it’s been over 20 years since its 1997 IPO.
What other investing lessons did Kevin and Tracey pass along on this special 200th episode?
Tune in to this week’s podcast to find out.
[In full disclosure, Tracey owns shares of AMZN in her personal portfolio.]
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Image: Shutterstock
Our Favorite Investing Lessons from the Last 20 Years
Welcome to Episode #200 of the Zacks Market Edge Podcast.
Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.
On this special episode, the 200th of the Market Edge Podcast, Kevin Cook, Zacks Senior Equity Strategist and Editor of the Healthcare Innovator newsletter, joins in the discussion on the investing lessons they have both learned over the last 20 years of investing.
What lessons have they learned that other investors can apply to their own strategies?
Two of Kevin’s Key Lessons
1. Trends: technology and healthcare innovation has stood the test of time over the last few decades. Kevin recommended buying the Technology Select SPDR ETF (XLK - Free Report) and the iShares NASDAQ Biotech ETF (IBB - Free Report) back in March 2009 as stocks were plunging. The XLK is up 392% since the March 2009 lows and the IBB is up 391% versus a 251% return on the S&P 500 over the same period. Also, individual companies such as Square (SQ - Free Report) are leading new industries.
2. ETFs: Use them for niche investing. Zacks ETF Investor bought the iShares Semiconductors ETF (SOXX - Free Report) back in 2016. That bet has paid off on a very narrow category in technology.
Two of Tracey’s Top Lessons
1. Buy the Best: don’t settle for the second-best company in the industry just because it may appear to be cheaper. Buy the industry leaders. In the 1990s, Tracey learned a hard lesson thanks to this.
2. You Don’t Have to Buy IPOs: There’s a lot of publicity surrounding “new” IPOs and many investors think it’s the only way to get a big winning stock. But you can buy an IPO years, or decades, later with much success. For example, Berkshire Hathaway recently bought Amazon (AMZN - Free Report) and it’s been over 20 years since its 1997 IPO.
What other investing lessons did Kevin and Tracey pass along on this special 200th episode?
Tune in to this week’s podcast to find out.
[In full disclosure, Tracey owns shares of AMZN in her personal portfolio.]
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>